Back

Selective beta-3 stimulation with mirabegron improves myocardial function and perfusion in a swine model of hibernated myocardium

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Basic science - cardiac disease 1 Heart Failure HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Mr Daniel Perez Camargo

San Carlos Clinical University Hospital, Madrid (Spain)

7 More presentations in this session

Presentation thumbnail
Predicting adverse cardiac remodeling after ST-elevation myocardial infarction with novel biomarkers soluble isoform of suppression tumorigenicity-2 and macrophage migration inhibitory factor
Associate Professor I. Vyshnevska (Kharkiv, UA)
Abstract Slides Video
Presentation thumbnail
Role of endothelial p22phox and SGLT2 interplay in pulmonary endothelial and vasculature dysfunction in isoproterenol-induced heart failure in mice
Ms S. Kerth (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Influence of oestrogen on Takotsubo syndrome
Mr E. Zulfaj (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Elucidation of the mechanistic links connecting non-alcoholic fatty liver disease and heart failure with preserved ejection fraction in mice
Associate Professor R. Asleh (Jerusalem, IL) Mrs N. Rweished (Jerusalem, IL)
Abstract Slides
Presentation thumbnail
Effects of LCZ696 on lipid metabolism in an animal model of heart failure with preserved ejection fraction (HFpEF). Possible implications for the management of obesity associated with HFpEF.
Mr O. Otero Garcia (Santiago de Compostela, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Basic science - cardiac disease 1

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Evaluating the efficacy and safety of beta-3 adrenergic receptor agonists in patients with heart failure: a systematic review and meta-analysis of randomized controlled trials
thumbnail
Congress Presentation
Cardiomyocyte-specific beta3-adrenergic receptor expression reduces infarct size inhibiting the autophagic flux in mice.
thumbnail
Congress Presentation
Treatment of diastolic dysfunction by targeting beta-adrenergic receptors in vivo in a murine model of cardiometabolic HFpEF

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources